Streamline the transition from development to manufacturing with our tech transfer and scale-up solutions. We have everything you need to get your biologics innovations to the finish line.
Tech transfer in biologics production involves transferring the processes developed during the discovery and development stages to the manufacturing stage. We can provide a streamlined tech transfer process for your biologics innovations, helping to ensure the successful commercialization of your products.
Tech transfer and scale-up are critical for bringing new biologics to market:
Tech transfer and scale-up are complex processes that require careful planning and execution to ensure the successful commercial production of high-quality biologics.
Tech transfer can be complex and time-consuming, leading to bottlenecks in product scale-up. Our tech transfer solutions can help you to plan, prepare, implement and validate tech transfer to streamline your product scale-up. An efficient tech transfer can reduce costs, improve product quality and accelerate the commercialization of your biologics innovations.
We are a global Continuously Innovative Development and Manufacturing Organization (CIDMO), dedicated to changing the paradigm by which affordable biologic and biosimilar medicines are brought to market. Since Enzene’s inception, our innovative agility has enabled us to continually introduce transformative processes in biologics manufacturing that significantly increase product yields of complex biologics and monoclonal antibodies (mAbs) while reducing the manufacturing footprint and the cost of production.
Game-changing innovation is only the beginning, though. We are Enzene, and that means that our values of innovation, entrepreneurship, respect, candor, excellence, and integrity underscore everything we do from project management and communications to teamwork and ideation. To us, true partnership is about driving biotech innovation while doing so in a way that develops long-lasting trusted partnerships.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.